Drug Trial Radar · NCT05795465
A Study of GEn-1124 in Subjects With Acute Respiratory Distress Syndrome (ARDS)
Last checked: Nov 19, 2026Latest source record: Jun 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
52
Planned (sponsor's estimate)
Start
Apr 4, 2023
Primary completion
Oct 2026
Study completion Dec 2026
Sponsor
- Lead sponsor
- GEn1E LifesciencesIndustry
- Sponsor type
- Industry
- First posted
- Apr 3, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
GEn1E-1124-002 is a two-part Phase 2 study to evaluate the safety and tolerability of GEn-1124 in subjects with ARDS. Treatment with IV infusion dosing as early as possible after ARDS diagnosis. Subjects will be given a second dose approximately 8 hours after the first dose and will continue with twice daily dosing (BID regimen) for 5 days.
Conditions
- Respiratory Distress Syndrome, Acute
Interventions
GEn-1124Drug
Intravenous infusion
PlaceboDrug
Intravenous infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- To assess the safety and tolerability (SAEs and TEAEs) of GEn-1124Time frame: Through study completion, Day 60
Locations
11 sites in 1 country. Site status is shown where the registry gives one.
Medstar Washington Hospital Center
Washington D.C., District of Columbia · Withdrawn
University of Kansas Medical Center
Kansas City, Kansas · Withdrawn
University of Maryland Medical Center
Baltimore, Maryland · Recruiting
University of Maryland - Baltimore Washington Medical Center
Glen Burnie, Maryland · Recruiting
Ocean Springs Hospital
Ocean Springs, Mississippi · Completed
Washington University School of Medicine
St Louis, Missouri · Withdrawn
Cooper University Hospital
Camden, New Jersey · Recruiting
The Mount Sinai Hospital
New York, New York · Withdrawn
Cleveland Clinic
Cleveland, Ohio · Recruiting
Houston Methodist Hospital
Houston, Texas · Withdrawn
Intermountain Medical Center
Murray, Utah · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.